British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Annals of oncology |
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Alimentary Pharmacology & Therapeutics (APT) |
Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease. |
déc. 15 |
2 ♥ |
MICI |
Journal of the National Cancer Institute (JNCI) |
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers |
sep. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial |
mai. 16 |
2 ♥ |
Foie |
British journal of Cancer |
Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial |
mai. 17 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. |
déc. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Clinical Gastroenterology and Hepatology |
Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed |
oct. 17 |
2 ♥ |
MICI |
British journal of Cancer |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Inflammatory Bowel Diseases |
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization |
oct. 15 |
2 ♥ |
MICI |
British journal of Cancer |
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study. |
juin. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
The Lancet |
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study. |
avr. 17 |
2 ♥ |
MICI |
Journal of clinical oncology (JCO) |
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Inflammatory Bowel Diseases |
Capsule Endoscopy: Diagnostic Accuracy of Lewis Score in Patients with Suspected Crohn's Disease |
oct. 15 |
2 ♥ |
MICI |
Endoscopy |
Long-term quality of life after peroral endoscopic myotomy remains compromised in patients with achalasia type III. |
déc. 17 |
2 ♥ |
Endoscopie/Imagerie |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Inflammatory Bowel Diseases |
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis |
aoû. 16 |
2 ♥ |
MICI |
British journal of Cancer |
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
sep. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Inflammatory Bowel Diseases |
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial |
mai. 17 |
2 ♥ |
MICI |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |